Adjuvant Docetaxel in Nonmetastatic Prostate Cancer: The King Is Dead, Long Live the King!

Eur Urol. 2023 Aug;84(2):164-165. doi: 10.1016/j.eururo.2023.05.033. Epub 2023 Jun 1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adjuvants, Immunologic
  • Chronic Disease
  • Docetaxel / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / pathology

Substances

  • Docetaxel
  • Adjuvants, Immunologic